Your browser doesn't support javascript.
loading
Nasal residence time and rheological properties of a new bentonite-based thixotropic gel emulsion nasal spray - AM-301.
Sailer, Martin M; Köllmer, Melanie; Masson, Beatrice; Fais, Fabio; Hohenfeld, Ilja P; Herbig, Michael E; Koitschev, Assen K; Becker, Sven.
Afiliación
  • Sailer MM; Department of Otorhinolaryngology, Head and Neck Surgery, St. Trudpert SILOAH Medical Center Pforzheim, Pforzheim, Germany.
  • Köllmer M; RaDes GmbH, Hamburg, Germany.
  • Masson B; IDD-Xpert, Evreux, France.
  • Fais F; Altamira Medica AG, Zug, Switzerland.
  • Hohenfeld IP; Altamira Medica AG, Zug, Switzerland.
  • Herbig ME; RaDes GmbH, Hamburg, Germany.
  • Koitschev AK; Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center of Eberhard-Karls University Tübingen, Germany, Tübingen, Germany.
  • Becker S; Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center of Eberhard-Karls University Tübingen, Germany, Tübingen, Germany.
Drug Dev Ind Pharm ; 49(1): 103-114, 2023 Jan.
Article en En | MEDLINE | ID: mdl-36852769
ABSTRACT

OBJECTIVE:

The present work provides characterization of rheological properties of a new bentonite-based thixotropic gel emulsion nasal spray (AM-301), its nasal residence time, distribution, safety and tolerability.

SIGNIFICANCE:

The nasal epithelium is a portal of entry for allergens and primary infection by airborne pathogens. Non-pharmacological interventions, which enhance physical and biological barriers, protect against allergens and pathogens without drug-related side effects. AM-301 has shown promising efficacy and safety in the nasal epithelium against viruses (in vitro) and pollen (clinical).

METHODS:

Technical part (i) spray characterization was performed with a validated droplet size distribution method; evaluation of the rheological properties of the formulation was performed by a validated amplitude sweep method and a validated oscillation, rotation, oscillation; Clinical part (ii) nasal and oropharyngeal endoscopy were used to provide a semi-quantitative evaluation of distribution and residence time of fluorescein-labelled AM-301 in the nose and oropharynx of healthy volunteers; (iii) tolerability and safety.

RESULTS:

(i) The non-Newtonian rheological properties of the formulation allow AM-301 to be sprayed and then to revert to a gel to prevent run-off from the nasal cavity; (ii) the formulation remains on the inferior turbinate, septum and oropharynx of volunteers for up to 210 min and on the middle turbinate for up to 60 min; two nasal sprays provide no substantial benefit over a single application with regards to coverage or retention; (iii) the spray is well tolerated.

CONCLUSIONS:

Single dose spray delivery of AM-301 provides extended coverage of the nasal mucosa up to the inferior turbinates.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Bentonita / Rociadores Nasales Límite: Humans Idioma: En Revista: Drug Dev Ind Pharm Año: 2023 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Bentonita / Rociadores Nasales Límite: Humans Idioma: En Revista: Drug Dev Ind Pharm Año: 2023 Tipo del documento: Article País de afiliación: Alemania